Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Annexon
Annexon
Annexon's neurological disease drug succeeds in late-stage study
Reuters
Tue, 06/4/24 - 11:46 am
Annexon
clinical trials
Guillain-Barré Syndrome
ANX005
Annexon finds more silver linings in failed eye disease trial ahead of talks with FDA
Fierce Biotech
Mon, 07/31/23 - 10:17 am
Annexon
clinical trials
geographic atrophy
ANX007
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Clinical Trials Arena
Thu, 05/25/23 - 08:25 pm
Annexon
clinical trials
ANX007
vision loss
geographic atrophy
This week's wave of biotech IPO players bumps up offerings and targets bigger harvests of cash
Endpoints
Thu, 07/23/20 - 11:16 am
IPOs
biotech
Inozyme Pharma
Annexon
AlloVir
Nurix Therapeutics
FDA grants fast track status to Annexon’s ANX005 to treat Guillain-Barré Syndrome
Pharmaceutical Business Review
Wed, 09/25/19 - 09:12 am
Annexon
fast track
FDA
ANX005
Guillain-Barré Syndrome
Annexon Biosciences Closes $75 Million Series C Round
CP Wire
Wed, 12/19/18 - 09:48 am
Annexon
Annexon Biosciences Closes $75 Million Series C Round
Wed, 12/19/18 - 09:48 am
Annexon
Novartis quarterbacks a $34M round for Huntington's startup Annexon
Fierce Biotech
Mon, 12/15/14 - 09:27 pm
Novartis
Huntington's disease
Annexon